| Anabolic Androgenic Steroid (AAS) data |
| AAS use (%) |
9.8 |
| Plan to use AAS in the future (%) |
6.8 |
| Friend as a source of information about AAS (%) |
41.5 |
| Gym trainer as a source of information about AAS (%) |
23.7 |
| Social media as a source of information about AAS (%) |
34.8 |
| Gym trainer provided participant with AAS substance (%) |
43.3 |
| Participant buys the AAS from online sites (%) |
39.7 |
| Participant buys the AAS from local drug stores (%) |
17.0 |
| AAS usage during the 1st gym year (%) |
34.0 |
| AAS usage during the 2nd gym year (%) |
26.3 |
| Participant seeks or plans to consult a medical provider about AAS (%) |
38.0 |
| Any fitness improvement experienced by the participant from AAS usage (%) |
76.7 |
| Participant advised other gym trainees to use AAS (%) |
52.7 |
| Complications experienced by the AAS users after quitting |
| AAS can cause depression after quitting (%) |
52.5 |
| AAS can cause muscle wasting after quitting (%) |
59.3 |
| Fitness will decrease after quitting AAS (%) |
54.4 |
| AAS can cause infertility after quitting (%) |
24.5 |
| AAS Type and route of Administration (Among users only) |
| Testosterone Enanthate (%) |
31.0 |
| Dianabol (%) |
30.8 |
| Deca durabolin (%) |
28.6 |
| Sustanon (%) |
20.0 |
| Winstrol (%) |
16.7 |
| Participant uses other types of AAS not listed above (%) |
37.3 |
| Participant does not know the type of AAS being used (%) |
24.8 |
| Oral administration of AAS (%) |
43.6 |
| Injectable administration of AAS (%) |
22.0 |
| Both oral and injectable administration of AAS (%) |
34.4 |
